Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Columbus, Ohio Ordinance Prohibits Employers from Inquiries into an Applicant’s Salary History

Client Alert

Effective March 1, 2024, Columbus employers are prohibited from inquiring into an applicant’s salary history. Specifically, the ordinance provides that it is an unlawful discriminatory practice to:

  • Inquire about the salary history of an applicant for employment;
  • Screen job applicants based on their current or prior wages, benefits, other compensation, or salary histories (including requiring that an applicant's history satisfy minimum or maximum criteria);
  • Rely solely on the salary history of an applicant in deciding whether to offer employment to an applicant, or in determining the salary, benefits, or other compensation; and
  • Refuse to hire or otherwise disfavor, injure, or retaliate against an applicant for not disclosing salary history.

Additionally, employers may not communicate with an applicant's current or prior employers to obtain an applicant’s salary history. Moreover, employers may not search publicly available records for the purpose of obtaining an applicant’s salary history. However, these prohibitions do not bar employers from discussing an applicant’s expectations regarding salary, benefits, and other compensation.

As defined by the ordinance, an “applicant” is any person applying for employment (whether interviewed or not) to be performed within the City of Columbus and whose application (in whole or in part) will be solicited, received, processed, or considered in the city of Columbus. An “employer” is defined as employing 15 or more persons within Columbus. Job placement and referral agencies are deemed employers when they operate on behalf of an “employer” as defined by the ordinance.

In response to an employer’s violation of the ordinance, an applicant may file a complaint with the Community Relations Commission. Depending on the number of violations, employers could face up to $5,000 in civil fines.

As provided within its text, the ordinance’s purpose is to eliminate hiring practices that “perpetuate issues of systemic discrimination related to the wage gap and wealth gap for women, especially women of color.”

In preparing for March 1, Columbus employers should assess and modify their current hiring practices to comply with the ordinance once it is in effect.

Should you have any questions regarding the ordinance or its implications, please contact BMD Member Daphne Kackloudis at dlkackloudis@bmdllc.com.


USCIS Policy Change Impacting Work Authorization: Advisory for Employers and Human Resources

USCIS has issued a policy memorandum pausing immigration benefit processing for individuals from 19 high-risk countries and requiring a re-review of certain previously approved cases. This change may affect work authorization, employment verification, and workforce stability. Employers and HR teams should review impacted employees and update compliance procedures.

CMS Releases CY 2026 Medicare Physician Fee Schedule Final Rule with Key Payment and Telehealth Updates

CMS issued the CY 2026 Medicare Physician Fee Schedule Final Rule on October 31, 2025, with changes effective January 1, 2026. The Final Rule includes increases to the conversion factor, a new efficiency adjustment, updates to practice expense methodology, permanent telehealth policy changes, revised payment for skin substitutes, expanded rules for Part B drugs and biologicals, enhanced policies for Rural Health Clinics and Federally Qualified Health Centers, and new care management and behavioral health services.

Ohio Department of Medicaid Updates: Key Changes to Physician Reimbursement Rates in Early Parenthood

The Ohio Department of Medicaid has proposed amending Ohio Administrative Code Rule related to covered Medicaid reimbursements for physicians. Beginning on January 1, 2026, they are proposing an increase to rates for prenatal care, childbirth, and infant care and provider visits.

Name, Image, and Likeness Agreements in Healthcare

For example, some healthcare providers have begun to utilize "Name, Image, and Likeness" agreements to promote the brand they have created through their healthcare practice.  We have seen the most healthcare NIL activity with longevity and wellness providers, as well as orthopedics.

Compounding GLP-1 Drugs - Recent Updates

Recent guidance from the Ohio Board of Pharmacy (“BOP”) indicates that providers should generally use the FDA approved GLP-1 drug, rather than a non-FDA approved compounded version of the medication. Importantly, if a GLP-1 drug is commercially available, it cannot be copied through compounding. Currently, compounded copies of Tirzepatide and Semaglutide are not permitted.